Global MiRNA Market 2023-2027
The MiRNA market is forecasted to grow by USD 2,020.12 mn during 2022-2027, accelerating at a CAGR of 18.91% during the forecast period. The report on the MiRNA market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of neurological disorders, significant scientific progress in MiRNA approach, and high heterogeneity of methodologies associated with MiRNA.
Technavio's MiRNA market is segmented as below:
By Type
By End-user
- Academic and government research institutes
- Biotechnology and pharmaceutical companies
- CROs and clinical diagnostic centers
By Geography
- North America
- Europe
- Asia
- Rest of World (ROW)
This study identifies the increasing number of partnerships and collaborations of market vendors as one of the prime reasons driving the MiRNA market growth during the next few years. Also, rapid growth potential in developing economies and growing adoption of artificial intelligence for disease evaluation will lead to sizable demand in the market.
The report on the MiRNA market covers the following areas:
- MiRNA market sizing
- MiRNA market forecast
- MiRNA market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading MiRNA market vendors that include BioGenex Laboratories Inc., BioVendor Laboratorni medicina AS, GeneCopoeia Inc., Genelinx International Inc., HEIM BIOTEK, Illumina Inc., InteRNA Technologies B.V., Merck KGaA, NanoString Technologies Inc., New England Biolabs Inc., OriGene Technologies Inc., PerkinElmer Inc., QIAGEN NV, Quantabio, Regulus Therapeutics Inc., SeqMatic LLC, Takara Bio Inc., TAMiRNA GmbH, Thermo Fisher Scientific Inc., and Miltenyi Biotec B.V. and Co. KG. Also, the MiRNA market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.